BR9604907B1 - derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral com princìpios ativos. - Google Patents

derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral com princìpios ativos.

Info

Publication number
BR9604907B1
BR9604907B1 BRPI9604907-3A BR9604907A BR9604907B1 BR 9604907 B1 BR9604907 B1 BR 9604907B1 BR 9604907 A BR9604907 A BR 9604907A BR 9604907 B1 BR9604907 B1 BR 9604907B1
Authority
BR
Brazil
Prior art keywords
homocarbocyclic
atom
pct
substituted
nucleoside derivatives
Prior art date
Application number
BRPI9604907-3A
Other languages
English (en)
Other versions
BR9604907A (pt
BRPI9604907B8 (pt
Inventor
Eui-Hwan Cho
Joong-Young Kim
Ho-Seok Kwon
Jeong-Ho Joo
Dong-Wook Kang
Sun-Gan Chung
Sun-Hwan Lee
Jae-Eung Lee
Byung-Chul Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019960047459A external-priority patent/KR100197792B1/ko
Priority claimed from KR1019960047458A external-priority patent/KR100197791B1/ko
Application filed filed Critical
Publication of BR9604907A publication Critical patent/BR9604907A/pt
Publication of BR9604907B1 publication Critical patent/BR9604907B1/pt
Publication of BRPI9604907B8 publication Critical patent/BRPI9604907B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
BRPI9604907A 1996-02-22 1996-12-30 derivados de nucleosidios homocarbociclico de pirimidinodiona substituída antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituída antiviral com princípios ativos. BRPI9604907B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19960004189 1996-02-22
KR19960025441 1996-06-28
KR1019960047459A KR100197792B1 (ko) 1996-06-28 1996-10-22 신규 항바이러스성 2-비스 (하이드록시메틸) 사이클로프로판-1- 메틸 피리미딘디온 유도체 및 그의 제조방법
KR1019960047458A KR100197791B1 (ko) 1996-02-22 1996-10-22 신규 항바이러스성 6위치에 치환된 피리미딘디온호모 카보사이 클릭 뉴클레오시드 유도체 및 그의 제조방법
PCT/KR1996/000265 WO1997030979A1 (en) 1996-02-22 1996-12-30 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients

Publications (3)

Publication Number Publication Date
BR9604907A BR9604907A (pt) 1998-07-21
BR9604907B1 true BR9604907B1 (pt) 2011-10-18
BRPI9604907B8 BRPI9604907B8 (pt) 2016-11-08

Family

ID=27483113

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9604907A BRPI9604907B8 (pt) 1996-02-22 1996-12-30 derivados de nucleosidios homocarbociclico de pirimidinodiona substituída antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituída antiviral com princípios ativos.

Country Status (14)

Country Link
US (1) US5922727A (pt)
EP (1) EP0827498B1 (pt)
JP (1) JP3049095B2 (pt)
CN (1) CN1092647C (pt)
AT (1) ATE243202T1 (pt)
AU (1) AU710490B2 (pt)
BR (1) BRPI9604907B8 (pt)
CA (1) CA2217026C (pt)
DE (1) DE69628750T2 (pt)
ID (1) ID15963A (pt)
MX (1) MX9708110A (pt)
RU (1) RU2138487C1 (pt)
TW (1) TW494098B (pt)
WO (1) WO1997030979A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6713486B1 (en) * 1999-03-04 2004-03-30 Korea Research Institute Of Chemical Technology Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
KR100311949B1 (ko) 1999-03-10 2001-11-02 최승주 1-[(사이클로펜트-3-엔-1-일)메틸]-5-에틸-6-(3,5-다이메틸벤조일)-2,4-피리미딘다이온의제조방법
KR20000065885A (ko) * 1999-04-10 2000-11-15 최승주 항바이러스성 피리미딘다이온 유도체 및 그 제조방법
KR101237312B1 (ko) 2006-02-10 2013-03-04 삼진제약주식회사 피리미딘다이온 유도체를 포함하는 c형 간염의 예방 및치료용 약학 조성물
MX2009000871A (es) * 2006-07-24 2009-05-08 Gilead Sciences Inc Novedosos inhibidores de transcriptasa inversa de vih.
MX2009013804A (es) * 2007-06-29 2010-02-03 Korea Res Inst Chem Tech Inhibidores novedosos de transcriptasa inversa de vih.
US8354421B2 (en) * 2007-06-29 2013-01-15 Korea Research Insitute Of Chemical Technology HIV reverse transcriptase inhibitors
US8119800B2 (en) * 2007-12-21 2012-02-21 Korea Research Institute Of Chemical Technology Processes for preparing HIV reverse transcriptase inhibitors
CN102603652A (zh) * 2011-12-27 2012-07-25 河南师范大学 5-甲酰基嘧啶碳环核苷及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730001A (en) * 1986-01-22 1988-03-08 Southern Research Institute Carbocyclic analogues of amino and azido thymidines
HU205917B (en) * 1989-09-29 1992-07-28 Mitsubishi Chem Ind Process for producing 6-substituted pyrimidine derivatives and antiviral pharmaceutical compositions containing them as active components
DE69126469T2 (de) * 1990-03-29 1998-01-29 Mitsubishi Chem Corp Pyrimidin-Nukleosid-Derivate und antivirale Mittel, die diese Derivate als aktiven Bestandteil enthalten
AU1994492A (en) * 1991-07-22 1993-02-23 Baker Cummins Pharmaceuticals, Inc. Acyclic 6-phenylselenenyl pyrimidine nucleosides
KR950011530A (ko) * 1993-10-21 1995-05-15 도바 다다스 사이클로프로판 유도체 및 이를 함유하는 항바이러스제
KR0151811B1 (ko) * 1993-12-21 1998-10-15 강박광 신규한 항바이러스성 2,4-피리미딘디온 유도체 및 그의 제조방법

Also Published As

Publication number Publication date
EP0827498A1 (en) 1998-03-11
ATE243202T1 (de) 2003-07-15
EP0827498B1 (en) 2003-06-18
ID15963A (id) 1997-08-21
JPH10507780A (ja) 1998-07-28
CN1092647C (zh) 2002-10-16
WO1997030979A1 (en) 1997-08-28
BR9604907A (pt) 1998-07-21
JP3049095B2 (ja) 2000-06-05
CA2217026A1 (en) 1997-08-28
RU2138487C1 (ru) 1999-09-27
CN1182420A (zh) 1998-05-20
BRPI9604907B8 (pt) 2016-11-08
DE69628750D1 (de) 2003-07-24
MX9708110A (es) 1998-06-30
AU1212497A (en) 1997-09-10
TW494098B (en) 2002-07-11
US5922727A (en) 1999-07-13
CA2217026C (en) 2001-11-20
DE69628750T2 (de) 2004-04-29
AU710490B2 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
BR0008770A (pt) Derivado de pirimidina, processo para a preparação de um derivado de pirimidina, processo para a produção de um efeito anti-câncer em um animal de sangue quente, uso de um derivado de pirimidina, e, composição farmacêutica
PT99358A (pt) Processo para a preparacao de composicoes farmaceuticas contendo aminoglicosidos e de reduzida nefrotoxicidade induzida por xantinas
DK0663907T3 (da) Fremgangsmåde til fremstilling af taxanderivater
HUP0302468A2 (hu) Alfa V integrin receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
DK151627C (da) Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.
BR9604907B1 (pt) derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral com princìpios ativos.
OA08825A (fr) Nouveaux dérivés de l'amino tétrahydro-5,6,7,8 naphto (2,3b) furanne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
KR920019738A (ko) 아미디노페닐알라닌 유도체, 이의 제조방법, 용도 및 이를 함유하는 조성물
DE69810746D1 (de) Sauerstoffenthaltende produkte als dieselbrennstoff
DK0623138T3 (da) Nye adenosinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
FR2699176B1 (fr) Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
UA48942C2 (uk) Похідне 1,3-оксазин-4-ону, проміжні сполуки для одержання даного похідного, гербіцидна композиція на його основі та спосіб боротьби з бур'янами
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
HRP20000733B1 (en) NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
HUP0001010A2 (hu) Benzimidazol-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
ATE1598T1 (de) 5(10- 9)abeo-ergolin-derivate, ihre herstellung und sie enthaltende therapeutische zusammensetzungen.
GB9115272D0 (en) Benzimidazole anthelmintics
KR950702566A (ko) 사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds)
KR970061875A (ko) 신규 항바이러스성 6위치에 치환된 피리미딘디온 호모 카보사이클릭 뉴클레오시드 유도체 및 그의 제조 방법
DE69521895D1 (de) Indolderivate als prodrugs von "5-ht1-like" rezeptor agonisten
AR005975A1 (es) Derivados antivirales de nucleosidos pirimidinadiona homocarbociclico substituido y metodos para la preparacion del mismo y las composicionesconteniendo lo mismo como ingrediente activo.
ATE25968T1 (de) 1,1-diphenylpropanol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR980002032A (ko) 신규 항바이러스성2-비스(하이드록시메틸)사이클로프로판-1-메틸 피리미딘디온 유도체 및 그의 제조 방법

Legal Events

Date Code Title Description
FD5 Application fees: dismissal - article 86 of industrial property law
B08G Application fees: restoration [chapter 8.7 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, DE ACORDO COM ARTIGO 37, TENDO POR BASE OS ARTIGOS 24 E 25 DA LPI 9279 DE 14/05/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/10/2011, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.68486/2013 ORIGEM: JUIZO DA 25A VARA FEDERAL DE SAO PAULO PROCESSO NO 0017574-93.2013.4.03.6100 ACAO DE NULIDADE DE PATENTE AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: BAYER SAS, CENTELION E CENTELION S.A., CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, MERCK SERONO S.A. E SAMJIN PHARMACEUTICAL CO. LTD.

B25G Requested change of headquarter approved
B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.068486/2013 SECAO JUDICIARIA DE SAO PAULO - 25A VARA FEDERAL CIVEL DE SAO PAULO PROCESSO NO0017574-93.2013.403.6100 AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: BAYER SAS, CENTELION, CENTELION S.A, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, MERCK SERONO S.A E SAMJIN PHARMACEUTICAL CO. LTDA DECISAO: JULGO PROCEDENTE O PEDIDO FORMULADO PARA DECLARAR A NULIDADE PARCIAL DAS PATENTES PI 9607583-0, PI 9610511-9, PI 9707889-1 E PI 9604907-3 E DETERMINO A RETIFICACAO DOS RESPECTIVOS PRAZOS DE VIGENCIA DE MODO A OBSERVAR A O DISPOSTO NO PARAGRAFO UNICO DO ARTIGO 229 DA LEI NO 9.279-96, EM INTERPRETACAO CONJUNTA COM O CAPUT DO ARTIGO 40 DO MESMO DIPLOMA.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2128 DE 18/10/2011, QUANTO AO PRAZO DE VALIDADE POR DETERMINACAO DA 25A VARA CIVEL FEDERAL DE SAO PAULO, PROC. 0017574-93.2013.403.6100 - ACAO ORDINARIA - INPI 52400.068486/2013-05.